ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changesYann Grobs, Sébastien Bonnet, Charlotte Romanet et al.|Science Translational Medicine|2024Cited by 33
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|Circulation|2025Cited by 26
Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial HypertensionYann Grobs, Sébastien Bonnet, Charifa Awada et al.|International Journal of Molecular Sciences|2021Cited by 16
Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionSarah‐Eve Lemay, Olivier Boucherat, Sandra Martineau et al.|American Journal of Respiratory and Critical Care Medicine|2024Cited by 15
Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studiesSarah‐Eve Lemay, Olivier Boucherat, Manon Mougin et al.|Cell Reports Medicine|2025Cited by 8